Reaction
Breast Operation reporting signals
As of the last recalculation, Breast Operation appears in 803 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE (PRR 129.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Conjugated Estrogens And Medroxyprogesterone Acetate | 103 | 129.6 | 130.2 |
| Medroxyprogesterone Acetate | 105 | 62.7 | 62.8 |
| Conjugated Estrogens | 105 | 53.6 | 53.7 |
| Estrogens, Conjugated | 105 | 52.6 | 52.7 |
| Ado-Trastuzumab Emtansine | 15 | 47.0 | 47.1 |
| Pertuzumab | 32 | 31.7 | 31.8 |
| Trastuzumab | 37 | 14.6 | 14.6 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 12.1 | 12.1 |
| Palbociclib | 30 | 8.4 | 8.4 |
| Bimekizumab | 6 | 7.3 | 7.4 |
| Oxymorphone Hydrochloride | 3 | 6.7 | 6.7 |